Abstract:Epilepsy is a common neurological disorder among all age groups and socioeconomic classes. Epilepsy surgery has been demonstrated to be a safe and effective treatment for drug-refractory epilepsy. Despite this success, many potential surgical candidates refuse surgery. On average, there is a 20-year delay between the diagnosis of epilepsy and surgical treatment,1 suggesting that epilepsy surgery is underutilized. The prevalence of active epilepsy is even higher in developing countries due to the limited availability and high cost of medication. To date, however, few studies have addressed the reasons for delayed surgical treatment in developing countries such as China. To address these issues, we conducted a cross-sectional survey to document potential barriers limiting patients access to the surgical treatment of epilepsy. METHODS The study was conducted at the Military General Hospital of Beijing People's Liberation Army from October 2009 to June 2013. Consecutive patients were enrolled according to the following criteria: (1) younger than 60 years, (2) diagnosis of epilepsy documented in medical files, (3) pharmacoresistance, defined as persistence of seizures after appropriate doses of two or more antiepileptic drugs (AEDs), (4) seizure frequency of at least one per month, (5) judged as a suitable surgical candidate, and (6) provided written informed consent. The typical presurgical evaluation included clinical examination, electroencephalogram (EEG)-video monitoring, magnetic resonance imaging with dedicated epilepsy protocol, positron emission computed tomography, single-photon emission computed tomography, neuropsychological testing, and Wada testing. Patients with a history of malignant brain tumor, previous neurosurgery (including epilepsy surgery), who were seizure free for at least 2 years at the last examination, who had tried <2 AEDs, or with primary generalized epilepsy according to the EEG were not considered potential candidates for epilepsy surgery. The questionnaire was composed of two parts. The first queried demographic and clinical characteristics, including the specific epilepsy syndrome, duration of the disease, current and previously failed AEDs, type and frequency of seizures during the past 12 months, and EEG and magnetic resonance imaging findings. The second part addressed issues pertaining to epilepsy surgery; if the patient rejected the surgical option, the reasons were documented. We divided participants into urban and rural dwellers, with an urban dweller defined as a participant living in a town or city for at least the past 3 years. All others were defined as rural dwellers. The completed questionnaire answers were entered into SPSS software (SPSS version 16.0; SPSS Inc., Chicago, IL, USA) for analysis. Descriptive statistics, primarily frequencies and percentages, were calculated. RESULTS A total of 410 patients completed the presurgical evaluation, of which 109 (26.6%) were judged not suitable for epilepsy surgery according to study criteria. Of the 304 patients judged suitable for surgery, 142 (46.7%) were treated surgically, while the remaining 162 (53.3%) refused surgery. Of those refusing surgery, 96 (59.3%) were male and 66 (40.7%) female. Mean age (±SD) was 26.9 (±10.9) years (range 3 years to 57 years) and 66.7% were rural residents. The mean duration of the seizure syndrome before visiting our epilepsy centre was 11.2 years (range 2–38 years) and the mean number of seizures per month was 8.3 (range 1–60). The mean number of failed AEDs was 3.4. All patients were examined by EEG and magnetic resonance imaging. The high cost of surgery was the primary reason given for refusing or postponing surgery, followed by anxiety over the risks of surgery, other reasons (did not want to take AEDs after surgery, still hoped that an AED would control seizures, etc.), advice of physician, did not expect good surgical outcome, and could not arrange a time (Table 1). Only a small minority (3.7%) failed to provide reasons for refusal. We also compared reasons for rejecting epilepsy surgery between urban and rural dwellers. The detail was shown in Table 1.Table 1: Reasons for the delay of epilepsy patients to surgery (n (%))DISCUSSION Over 1.8 million of epilepsy patients in China are likely suitable candidates for surgery, and this number is increasing by 120 000 patients every year. However, no more than 2 500 epilepsy operations are currently performed per year.2 In light of these data, there is an urgent need to remove all obstacles barring access to epilepsy surgery, particularly for candidates in the early stage of seizure intractability. In our study, the cost of surgery was the primary reason for candidates to refuse or postpone surgery. Epilepsy surgery has proven to be both feasible and cost-effective in developing countries.3 In most developed countries, patient health care costs are covered by a national health system or private insurance, while patients in less wealthy countries are often expected to pay most or all treatment costs. The annual cost of continued medical treatment amounts to 20.2% of mean annual family income,4 placing a heavy economic burden on patients. In our study, many patients reported that this out-of-pocket, one-time payment for surgery was too costly. This number was even higher for rural patients. Patient beliefs can be important additional obstacles to epilepsy surgery, patients with epilepsy often overestimate the risks. In this study, apprehension over surgical risk was the second most frequent reason cited for refusing surgery. In reality, mortality associated with epilepsy surgery is <1% and only 3% of patients are left with permanent neurological deficits.5 Alternatively, some patients may have unrealistic expectations. Indeed, some stated that they would not undergo surgery unless “100% certain” that seizures would be completely controlled. Thus, providing accurate and objective information is the key to patient acceptance. Physicians should be aware that patient attitudes toward epilepsy surgery can create barriers to a potentially curative treatment. Providing accurate information, such as why epilepsy surgery is indicated, the risks involved, how surgery may affect memory and language, and the expected success rate, is the most appropriate way to deal with misguided notions such as “surgery is only a last resort” or there must be “100% certainty” of success. A major reason for the delay in time to surgery is lack of timely referral to epilepsy surgery centers by the treating neurologist or primary care physician. In our study, 11.1% of patients cited this as a reason for refusing surgery. There are multiple sources of information available to patients, but most prefer to receive counsel directly from their primary physician. Thus, the physician has a crucial role in providing pertinent information that will enable the patient to make an informed decision about surgery. Possible reasons for this poor referral pattern are (1) the unclear definition of refractory epilepsy, as some neurologists require failure of four or more antiepileptic medications before considering surgery, (2) inaccurate or incomplete information about the indications and expected outcome of epilepsy surgery, and (3) overestimating the incidence of surgical complications. In fact, some patients judged suitable for surgery after our presurgical evaluation did refuse based on the advice of their personal physician. The true proportion of patients delaying or refusing surgery could be even higher. Therefore, epilepsy centers should update the referring physician at every step of the evaluation process. Most importantly, attempts should be made to change the recalcitrant physician's views on epilepsy surgery. The main limitation of this cross-sectional study is the sample selection. Patients referred to epilepsy centers are usually those seeking alternative treatment options, including surgery, so it is possible that epilepsy patients not seeking further treatment have significantly different views on epilepsy surgery.

Managing Expectations of Epilepsy Surgery

Presurgical Evaluation Strategies for Intractable Epilepsy of Childhood

Lost in Transition: The Long and Winding Road Toward Epilepsy Surgery—An Analysis of Obstacles Prior to Surgery and Call for Orchestrated Health Care Efforts in Epilepsy

Surgical Treatment for Epilepsy: the Potential Gap Between Evidence and Practice.

Why Patients with Refractory Epilepsy Reject Surgery in China

Factors Affecting Seizure Outcome after Epilepsy Surgery: an Observational Series

Patient, Parent and Carer Perspectives Surrounding Expedited Paediatric Epilepsy Surgery

Epilepsy surgery perceptions among general neurologists and epilepsy specialists: A survey

The Long-Term Outcome of Adult Epilepsy Surgery, Patterns of Seizure Remission, and Relapse: A Cohort Study

Surveying neurologist perspectives and knowledge of epilepsy surgery to identify barriers to surgery referral

The role of psychology and neuropsychology in pediatric epilepsy surgery evaluation

Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy

Clinical Predictors of 2-Year Outcome of Resective Epilepsy Surgery in Adults with Refractory Epilepsy: a Cohort Study

Predictors of Outcome in the Surgical Treatment for Epilepsy.

Referral to evaluation for epilepsy surgery: Reluctance by epileptologists and patients

Out of Sight, Not Yet Out of Reach: Surgical Outcomes in MRI-Negative and Pathology-Negative Epilepsy Patients

018 Optimising selection for epilepsy surgery

Long-term Seizure, Psychiatric and Socioeconomic Outcomes after Frontal Lobe Epilepsy Surgery.

Sharper Minds: Cognitive Recovery After Epilepsy Surgery in Children

Readability and content gaps in online epilepsy surgery materials as potential health literacy and shared-decision-making barriers

Epilepsy Surgery: Special Circumstances